Researchers seek FDA approval for diabetes cell transplants

05/14/2013 | Denver Post, The

A consortium led by the University of Minnesota is preparing to seek FDA approval of a potential breakthrough treatment for type 1 diabetes that involves transplanting insulin-producing islet cells. Clinical studies have demonstrated that 60% to 70% of patients receiving the transplants remained insulin-free after five years. Approximately 1.5 million Americans have type 1 diabetes, in which the body destroys its own islet cells.

View Full Article in:

Denver Post, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC